| Language | English |
|---|---|
| Pages | 831-842 |
| Journal | Expert Opinion on Biological Therapy |
| Volume | 7 |
| Issue number | 6 |
| Publication status | Published - 2007 |
Keywords
- Duchenne muscular dystrophy
- antisense oligonucleotides
- morpholinos
- exon skipping
Cite this
Yokota, T., Pistilli, E., Duddy, W., & Nagaraju, K. (2007). Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. Expert Opinion on Biological Therapy, 7(6), 831-842.
@article{23963ef915164958aadafd8aad9368fc,
title = "Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy",
keywords = "Duchenne muscular dystrophy, antisense oligonucleotides, morpholinos, exon skipping",
author = "Toshifumi Yokota and Emidio Pistilli and William Duddy and Kanneboyina Nagaraju",
year = "2007",
language = "English",
volume = "7",
pages = "831--842",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
number = "6",
}
Yokota, T, Pistilli, E, Duddy, W & Nagaraju, K 2007, 'Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy', Expert Opinion on Biological Therapy, vol. 7, no. 6, pp. 831-842.
Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. / Yokota, Toshifumi; Pistilli, Emidio; Duddy, William; Nagaraju, Kanneboyina.
In: Expert Opinion on Biological Therapy, Vol. 7, No. 6, 2007, p. 831-842.Research output: Contribution to journal › Article
TY - JOUR
T1 - Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy
AU - Yokota, Toshifumi
AU - Pistilli, Emidio
AU - Duddy, William
AU - Nagaraju, Kanneboyina
PY - 2007
Y1 - 2007
KW - Duchenne muscular dystrophy
KW - antisense oligonucleotides
KW - morpholinos
KW - exon skipping
M3 - Article
VL - 7
SP - 831
EP - 842
JO - Expert Opinion on Biological Therapy
T2 - Expert Opinion on Biological Therapy
JF - Expert Opinion on Biological Therapy
SN - 1471-2598
IS - 6
ER -
Yokota T, Pistilli E, Duddy W, Nagaraju K. Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. Expert Opinion on Biological Therapy. 2007;7(6):831-842.